Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

@article{Plana2014ExpertCF,
  title={Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.},
  author={J. Plana and M. Galderisi and A. Barac and M. Ewer and B. Ky and M. Scherrer‐Crosbie and J. Ganame and I. Sebag and D. Agler and L. Badano and J. Banchs and D. Cardinale and J. Carver and M. Cerqueira and J. DeCara and T. Edvardsen and S. Flamm and T. Force and B. Griffin and G. Jerusalem and Jennifer E. Liu and A. Magalh{\~a}es and T. Marwick and L. Sanchez and R. Sicari and H. Villarraga and P. Lancellotti},
  journal={European heart journal cardiovascular Imaging},
  year={2014},
  volume={15 10},
  pages={
          1063-93
        }
}
### A. Definition, classification, and mechanisms of toxicity Cardiac dysfunction resulting from exposure to cancer therapeutics was first recognized in the 1960s, with the widespread introduction of anthracyclines into the oncological therapeutic armamentarium.1 Heart failure (HF) associated with anthracyclines was then recognized as an important side effect. As a result, physicians learned to limit their doses to avoid cardiac dysfunction.2 Several strategies have been used over the past… Expand
Role of Imaging in Cardio-Oncology
TLDR
Various imaging modalities and emerging techniques that can assist in detecting early signs of cardiotoxicity and thus reduce the incidence of cardiac disease in cancer survivors are discussed. Expand
Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging.
TLDR
Recommendations for the use of multimodality imaging according to the clinical question are provided with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. Expand
Comparison of conventional and advanced echocardiographic techniques in early detection of cardiotoxicity in patients undergoing cancer chemotherapy
TLDR
A 10%–15% early reduction in global longitudinal strain (GLS) by speckle tracking echocardiography proposed to be the earliest indicator of myocardial dysfunction in patients undergoing cancer chemotherapy. Expand
The Current and Future Role of Echocardiography for the Detection of Cardiotoxicity Related to Cancer Therapy
TLDR
Echocardiography is the preferred imaging modality for the detection of cardiotoxicity related to cancer therapy, and expanded understanding of the cardiac side effects of cancer therapy and optimal surveillance strategies for those at risk is predicated on the ascertainment of cardiac outcomes in future clinical trials. Expand
Update in imaging of cancer therapy-related cardiac toxicity in adults
TLDR
New insights and recent results in literature regarding echocardiographic and cardiac magnetic resonance imaging of cancer therapy-related cardiac dysfunction in post-cancer therapy adults will be highlighted. Expand
Cardiac Image The Early Predictive Value of Right Ventricular Strain in Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer
Background: As cancer therapies have improved, patient life spans have been extended but quality of life has been threatened by chemotherapy induced cardiotoxicity. Most cardiac complications remainExpand
Importance of cardio-oncology. How to detect suclinical heart failure.
TLDR
There are multiple factors that increase the sensitivity of anthracyclic-induced cardiotoxicity and these results can be complemented with cardiac biomarkers (troponins) and electrocardiographic changes for a comprehensive assessment. Expand
Role of new echocardiographic techniques in the detection of cancer treatment-related cardiac dysfunction . Current status and further perspectives
Contact address: Denisa Muraru, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Via Giustiniani 2, 35128 Padua, Italy. E-mail: denisa.muraru@gmail.com 1 Department ofExpand
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC)
TLDR
The role of echocardiographic parameters, including global longitudinal strain and three‐dimensional ejection fraction, are proposed and the protocol for baseline pre‐treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2‐targeted therapies such as trastuzumab and vascular endothelial growth factor tyrosine kinase inhibitors are presented. Expand
Diagnosis, Treatment, and Prevention of Cardiovascular Toxicity Related to Anti-Cancer Treatment in Clinical Practice: An Opinion Paper from the Working Group on Cardio-Oncology of the Korean Society of Echocardiography
TLDR
The CV toxicity is summarized and the role of cardiac imaging in management strategies for cardiotoxicity associated with anti-cancer treatment is focused on, with a focus on serologic biomarkers or cardiac imagings. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 261 REFERENCES
Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.
TLDR
An evidence-based review of several imaging approaches used to detect, evaluate, and monitor RIHD is discussed and recommendations for the early identification and monitoring of cardiovascular complications of radiotherapy by cardiac imaging are proposed. Expand
Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.
TLDR
The value of echocardiographicMyocardial deformation parameters for the early detection of myocardial changes and prediction of cardiotoxicity in patients receiving cancer therapy is confirmed. Expand
Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.
TLDR
Noncontrast 3DE was the most reproducible technique for LVEF and LV volume measurements over 1 year of follow-up and had the best intra- and inter-observer as well as test-retest variability. Expand
Doxorubicin cardiotoxicity: Prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era
TLDR
An incipient fall in LVEF detected on serial ERNA during doxorubicin therapy provides an appropriate and cost-effective approach for predicting and preventing impending CHF. Expand
Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group.
TLDR
Treatment according to third and fourth generation clinical trial protocols of the GHSG leads only to minimal wall motion changes, without concomitant reduction of left ventricular function, thus not meeting the criteria, acute cardiotoxicity. Expand
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Background—Because cancer patients survive longer, the impact of cardiotoxicity associated with the use of cancer treatments escalates. The present study investigates whether early alterations ofExpand
Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging.
  • G. Armstrong, J. Plana, +11 authors S. Flamm
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2012
TLDR
CMR identified a high prevalence of cardiomyopathy among adult survivors previously undiagnosed with cardiac disease and should be considered for comprehensive cardiac assessment, which may include CMR. Expand
Serum Markers, Conventional Doppler Echocardiography and Two-dimensional Systolic Strain in the Diagnosis of Chemotherapy-Induced Myocardial Toxicity
TLDR
Natriuretic peptides and two-dimensional LS and RS were useful to predict mild ventricular systolic dysfunction in chemotherapy-treated patients. Expand
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines.
TLDR
In conclusion, myocardial scar by late gadolinium enhancement-CMR is infrequent in patients with anthracycline-cardiomyopathy despite a reduced ejection fraction, the event rate in Patients with established anthrACYcline -cardiotoxicity is high, and indexed LV mass by CMR imaging is a predictor of adverse cardiovascular events. Expand
Early Diagnosis of Chemotherapy-induced Cardiomyopathy: a Prospective Tissue Doppler Imaging Study
TLDR
The results confirmed assumptions that TDI is a more precise and useful examination method than the traditional ones (E/A ratio or deceleration time) to demonstrate isolated diastolic dysfunction and may become a regularly and more widely used noninvasive method to detect subclinical cardiotoxicity emerging after chemotherapy. Expand
...
1
2
3
4
5
...